Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8397
Reference
Drug alert 10/2025
Name
Drug Alert Class 2 Drug Alert 10 2025 – Class 2 medicines recall – action within 48 hours – Aspar Pharmaceuticals Ltd – Boots Paracetamol 500mg tablets (16s)
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Drugs
Safety
Risks
Pharmaceutical Services
Medicines Recall
Description
Aspar Pharmaceuticals Limited have informed the MHRA of an error related to Boots Paracetamol 500 mg tablets (16s), a product manufactured by Aspar Pharmaceuticals Limited and distributed by The Boots Company PLC.
Following a customer complaint, it was identified that the foil blister inside the carton of Paracetamol 500 mg tablets (16s), incorrectly states ‘Aspirin 300 mg Dispersible Tablets’. Aspar pharmaceuticals have retrieved and inspected the reported batch and confirmed that the tablets in the blister packs are Paracetamol 500 mg tablets. This batch was first distributed on 14/01/2025 and any customers or patients who have purchased the product should return the packs to Boots stores for a full refund, with or without a receipt.
The impacted batch is only sold in Boots stores and Boots online pharmacy and does not impact any other products or batches that share the same PL number packaged in different liveries. If you have any concerns, please contact Aspar Pharmaceuticals Limited using the details below.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
Contact Phone
Created
2025-03-04 16:05:05
Click to go back to homepage